Clinical Trial Update: EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan

View source ↗

Summary

A completed post-marketing surveillance study in Japan evaluating the AMD-QOL quality of life measure for patients with age-related macular degeneration treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Macular Degeneration | Status: COMPLETED